Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
Ankit Kansagra(Southwestern Medical Center), Shahrukh K. Hashmi(Sheikh Shakhbout Medical City), John Barrett(George Washington University), David G. Maloney(Fred Hutch Cancer Center), Mohamed A. Kharfan‐Dabaja(Mayo Clinic in Florida), Paul A. Carpenter(Fred Hutch Cancer Center), Mohamad Mohty(Inserm), Helen E. Heslop(Houston Methodist), Nirali N. Shah(National Institutes of Health), Ali Bazarbachi(American University of Beirut Medical Center), Leslie A. Andritsos(The Ohio State University Wexner Medical Center), Saar Gill(California University of Pennsylvania), David L. Porter(University of Pennsylvania), Laura Johnston(City Of Hope National Medical Center), Saad S. Kenderian(Mayo Clinic), Hien Liu(Moffitt Cancer Center), Elizabeth J. Shpall(The University of Texas MD Anderson Cancer Center), Krishna V. Komanduri(University of Miami), Arnon Nagler(Tel Aviv University), Michel Sadelain(Memorial Sloan Kettering Cancer Center), Christian Chabannon(Inserm), John F. DiPersio(Washington University in St. Louis), Steven Z. Pavletic(National Institutes of Health), Merav Bar(Fred Hutch Cancer Center), Veronika Bachanová(University of Minnesota), Partow Kebriaei(Cellular Therapeutics (United Kingdom)), Chiara Bonini(Vita-Salute San Raffaele University), Stephan A. Grupp(Children's Hospital of Philadelphia), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Armin Ghobadi(Washington University in St. Louis), Elad Jacoby(National Institutes of Health), Theodore W. Laetsch(Center for Cancer and Blood Disorders), Bipin N. Savani(Vanderbilt University Medical Center), Noelle V. Frey(University of Pennsylvania), Michael Hudecek(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Dennis A. Gastineau, Mark R. Litzow(Toyota Motor Corporation (Switzerland)), Joshua A. Hill(Infectious Disease Research Institute), Ghulam J. Mufti(King's College London), Catherine M. Bollard(Houston Methodist)
Cited by 119
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k